[HTML][HTML] Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects

PS Rao, AD Harris - F1000Research, 2018 - ncbi.nlm.nih.gov
This review discusses the management of ventricular septal defects (VSDs) and
atrioventricular septal defects (AVSDs). There are several types of VSDs: perimembranous …

[HTML][HTML] Percutaneous transcatheter closure of congenital ventricular septal defects

J Song - Korean Circulation Journal, 2023 - synapse.koreamed.org
Ventricular septal defects (VSDs) are the most common kind of congenital heart disease
and, if indicated, surgical closure has been accepted as a gold-standard treatment …

Recommended standards for the performance of transesophageal echocardiographic screening for structural heart intervention: from the American Society of …

RT Hahn, M Saric, FF Faletra, R Garg… - Journal of the …, 2022 - onlinejase.com
Rebecca T. Hahn, MD, FASE (Chair), Muhamed Saric, MD, PhD, FASE (Co-Chair),
Francesco Fulvio Faletra, MD, Ruchira Garg, MD, FASE, Linda D. Gillam, MD, MPH, FASE …

Percutaneous closure of restrictive‐type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: midterm outcomes of the first …

RN Haddad, LS Daou, ZS Saliba - Catheterization and …, 2020 - Wiley Online Library
Objectives To evaluate the safety, efficiency, and midterm outcomes of transcatheter
perimembranous ventricular septal defect (pmVSD) closure using the new KONAR‐MF™ …

Short-and long-term outcome after interventional VSD closure: a single-center experience in pediatric and adult patients

M Bergmann, CP Germann, J Nordmeyer, B Peters… - Pediatric …, 2021 - Springer
Interventional closure of congenital ventricular septal defects (VSD) is recording a
continuous rise in acceptance. Complete atrioventricular block (cAVB) and residual shunting …

Device closure of perimembranous ventricular septal defect: choosing between amplatzer occluders

RN Haddad, L Daou, Z Saliba - Frontiers in Pediatrics, 2019 - frontiersin.org
Background: Off-label device closure of perimembranous ventricular septal defect (pmVSD)
is well reported in the literature with encouraging results. However, technical challenges …

Transcatheter ventricular septal defect closure with Lifetech™ Konar-MF Occluder in infants under 10 kg with only using venous access

İ Ece, D Bağrul, AV Kavurt, H Terin, G Torun, S Koca… - Pediatric …, 2024 - Springer
Transcatheter closure of VSD remains a complex procedure in infants with technical
challenges and carries the risk of significant complications, due to its complex anatomical …

Long-term outcome of transcatheter device closure of perimembranous ventricular septal defects

KD Mandal, D Su, Y Pang - Frontiers in pediatrics, 2018 - frontiersin.org
Background: Ventricular septal defect is a common congenital heart defect. Transcatheter
closure of perimembranous ventricular septal defect (pmVSD) is an effective method …

Percutaneous ventricular septal defect closure in patients under 1 year of age

N Narin, O Pamukcu, A Tuncay, A Baykan, S Sunkak… - Pediatric …, 2018 - Springer
Untreated ventricular septal defect (VSD) is an important cause of congestive heart failure in
early infancy. Growth is impaired in this population, and surgical closure is challenging …

Comparative outcomes of two competitive devices for retrograde closure of perimembranous ventricular septal defects

RN Haddad, ZS Saliba - Frontiers in Cardiovascular Medicine, 2023 - frontiersin.org
Background Retrograde closure of perimembranous ventricular septal defects (pmVSDs) is
a well-established procedure. However, interventionists are still looking for the best closure …